Not yet recruiting NCT07117253
Interstitial Lung Diseases in Respiratory ICU
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Interstitial Lung Diseases. Basic parameters: No limits · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Factors Affecting Outcome of Patients With Interstitial Lung Diseases in Respiratory Intensive Care Unit
Overview
This is Prospective observational study to analyze the clinical features, risk factors, outcome,mortality rates in interstitial lung diseases patients who required admission in Respiratory ICU
Primary outcome measures
- Number of participants with Complications of disease [Time frame: 1 month after icu admission]
- Evaluate Length of respiratory ICU stay [Time frame: 1 month after icu admission]
- Assess mortality of patients with interstitial lung diseases in respiratory icu. [Time frame: 1 month after icu admission]
Eligibility criteria
Inclusion criteria
- Patients who had diagnosis of interstitial lung diseases required admission in respiratory ICU
Exclusion criteria
- Patients with respiratory diseases other than ILD
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT07117253 · Soh-Med-24-10-8MS